🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Brian Morreale

Roswell Park Comprehensive Cancer Center

ORCID: 0000-0002-0157-7026
MedicineImmunology and MicrobiologyBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

0in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression”.

Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression

Journal of Clinical Investigation(2022)10.1172/jci158661
N/A
0DataRank · unranked
48 citations

Andrea M. Amitrano, Robert Zollo, Jennifer Peresie, Elliot D. Kramer, Brian Morreale +9 more

Downregulation of IRF8 in alveolar macrophages by G-CSF promotes metastatic tumor progression

iScience(2024)10.1016/j.isci.2024.109187
N/A
0DataRank · unranked
3 citations

Elliot D. Kramer, Hemn Mohammadpour, Minhyung Kim, Spencer R. Rosario, Han Yu +14 more

ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast Cancer

Annals of Surgical Oncology(2025)10.1245/s10434-025-18260-2
N/A
0DataRank · unranked
4 citations

Kohei Chida, Rongrong Wu, Kohei Taniguchi, Amber McKenery, Brian Morreale +11 more

ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2– Breast Cancer: A New Role for ESR1?

Annals of Surgical Oncology(2025)10.1245/s10434-025-18377-4
N/A
0DataRank · unranked
0 citations

Kohei Chida, Rongrong Wu, Kohei Taniguchi, Amber McKenery, Brian Morreale +17 more